Low Bone Mineral Density as a Risk Factor for Liver Cirrhosis

Author:

Zhang Xiaowen1,Cheung Ka-Shing23,Mak Lung-Yi24,Tan Kathryn C B2,Kung Annie W C2,Wong Ian Chi-Kei156,Cheung Ching-Lung15ORCID

Affiliation:

1. Department of Pharmacology and Pharmacy, The University of Hong Kong , Pokfulam, Hong Kong Special Administrative Region , China

2. Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Pokfulam, Hong Kong Special Administrative Region , China

3. Department of Medicine, The University of Hong Kong-Shenzhen Hospital , Shenzhen 518053 , China

4. State Key Laboratory of Liver Research, The University of Hong Kong , Hong Kong Special Administrative Region , China

5. Laboratory of Data Discovery for Health Limited (D24H), Hong Kong Science Park , Pak Shek Kok, Hong Kong Special Administrative Region , China

6. Research Department of Practice and Policy, School of Pharmacy, University College London , London WC1N 1AX , UK

Abstract

Abstract Context Bone metabolism interplays with liver metabolism, also known as the liver-bone axis. Osteoporosis is a common complication of cirrhosis, but whether bone mineral density (BMD) can predict cirrhosis development is unknown. Objective This study aims to investigate the relationship between BMD and the risk of incident cirrhosis in the Hong Kong Osteoporosis Study (HKOS). Methods BMD was measured at the lumbar spine, femoral neck, total hip, and trochanter of 7752 participants by dual-energy x-ray absorptiometry (DXA), and the incidence of cirrhosis and mortality were followed by linking to the territory-wide electronic health records database. Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% CI. Results With a median follow-up of 18.43 years, 42 incident cirrhosis were identified. Higher BMD T-scores at the femoral neck, total hip, and trochanter were significantly associated with a reduced risk of cirrhosis (femoral neck: HR 0.56; 95% CI, 0.39-0.82; total hip: HR 0.60; 95% CI, 0.44-0.82; trochanter: HR 0.63; 95% CI, 0.46-0.88). Similar associations were observed in participants without risk factors of cirrhosis at the baseline and further adjusting for the baseline level of alkaline phosphatase, albumin, and alanine transaminase. Consistent relationships in multiple sensitivity analyses suggest the robustness of the results. Conclusion Low BMD could be a novel risk factor and early predictor for cirrhosis, with consistent associations observed in multiple sensitivity analyses.

Publisher

The Endocrine Society

Reference43 articles.

1. Global epidemiology of chronic liver disease;Cheemerla;Clin Liver Dis (Hoboken),2021

2. Liver cirrhosis;Ginès;Lancet,2021

3. Global epidemiology of cirrhosis—aetiology, trends and predictions;Huang;Nat Rev Gastroenterol Hepatol,2023

4. The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis;Wiegand;Dtsch Arztebl Int,2013

5. Defects in a liver-bone axis contribute to hepatic osteodystrophy disease progression;Lu;Cell Metab,2022

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3